Ocular pharmacokinetics of saperconazole in rabbits. A potential agent against keratomycoses.

Keywords

Cornea, Pharmacokinetics, Clearance, Medicine, Pharmacology

References

• Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animalsJ. Van Cutsem, F. Van Gerven, Patricia A. Janssen — 1989
• Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives.Josef Pitha, Tetsumi Irie, Pamela Sklar — 1988
• The Cornea: Scientific foundations and clinical practiceGilbert Smolin, R A Thoft — 1983
• Pharmacologic management of keratomycoses.Karla J. Johns, Denis M. O’Day — 1988
• Structural degeneration of Aspergillus fumigatus after exposure to saperconazole.Μ. Borgers, Marie-Anne A. Van de Ven, J. Van Cutsem — 1989
• Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansMichael Humphrey, S. Jevons, Michael H. Tarbit — 1985
• Toxicity and Pharmacokinetics of Subconjunctival Amphotericin B: An Experimental StudyDenis M. O Day, Richard S. Smith, Jacquelyn B. Stevens — 1991
• Ocular uptake of fluconazole following oral administration.Denis M. O’Day — 1990
• Fluconazole Penetration into Cerebrospinal Fluid in HumansGeorge Foulds, Doreen R. Brennan, Charles P. Wajszczuk — 1988
• Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitisD V Savani, John R. Perfect, L. Michael Cobo — 1987
• Comparative efficacy of new azole antifungal agents against human ocular isolatesNettie M. Robinson, Rebecca L. Penland, Michael S. Osato — 1990

Cited by

• The changing spectrum of fungal keratitis in south Florida.Robert H. Rosa, Darlene Miller, Eduardo C. Alfonso — 1994
• Advances in the Management of Keratomycosis and Acanthamoeba KeratitisDenis M. O’Day, W. Steven Head — 2000
• Animal models of Aspergillus infection in preclinical trials, diagnostics and pharmacodynamics: What can we learn from them?Karl V. Clemons, David A. Stevens — 2006
• Animal models: an important tool in mycologyJavier Capilla, Karl V. Clemons, David A. Stevens — 2007
• The relationship of corneal epithelial defect size to drug penetration.D A Johnson — 1995
• THERAPY OF OCULAR FUNGAL INFECTIONSThomas O’Brien — 1999
• Rabbit Model of Candida KeratomycosisM. Motschmann, W. Behrens-Baumann — 1999
• Ocular Pharmacokinetics and PharmacodynamicsR. Schoenwald — 2003
• Aspergillose aviaire : développement d’un modèle d’aspergillose chez la dinde (Meleagris gallopavo) et évaluation de l’efficacité de l’énilconazoleE. Melloul, E. Melloul — 2015

Related papers

• The pulmonary clearance of bacteria by calves and mice.L. E. Lillie, R. G. Thomson — 1972
• A survey of additive manufacturing trends for FDA-cleared medical devicesMagdalene Fogarasi, Kirstie Snodderly, Matthew Di Prima — 2023
• Hot vs. Cold Cases: Examining Time to Clearance for Homicides Using NIBRS DataLynn A. Addington — 2007
• Various reports. The editorial floor, cleared of reports following reviews in The Gazette for October, 1965, has filled up again and must be re-cleared.E. A. Maxwell — 1966
• Studies on the components of Sokokju (old Korean cleared rice wine) and commercial Yakju (Korean cleared rice wine)Kuei-min Chang, Te-chün Yü — 1981
• Analysis of iosulamide in plasma and urine: application to intravenous pharmacokinetics in rhesus monkey.G B Park, Charles E. Biddlecome, E. Rowe — 1981
• The prevention effect of cyclosporine A nano-particle eye drop on cornea immune rejection in a rat penetrating cornea transplantation modelYou Yu-xi — 2012